Figure 1.
Senescence marker protein 30 (SMP30) levels in glandular epithelial cells correlate with malignancy of mammary gland tumors in dogs and cats. (A) Representative images of hematoxylin and eosin (H&E) staining and immunohistochemistry stained with anti-SMP30 normal tissue, adenoma, carcinoma (grade 1), and mammary carcinoma (grade 2). Significantly higher SMP30 expression was observed with an increase in malignancy of mammary gland tumors. Scale bars = 100 μm. Inset, scale bars = 50 μm. (B) Immunohistochemistry intensity scoring for SMP30 expression examined in canine mammary gland tumors. SMP30 expression significantly increased in carcinoma whereas adenoma showed a low level of SMP30 (** p < 0.01). (C) Representative images of H&E staining and immunohistochemistry of mammary specimens from felines with mammary carcinoma (grade 1) and mammary carcinoma (grade 2). A higher SMP30 expression level was observed in glandular epithelial cells of mammary carcinoma (grade 2) than that of mammary carcinoma (grade 1). Scale bars = 100 μm. Inset, scale bars = 50 μm. (D) Immunohistochemistry intensity scoring for SMP30 expression in feline mammary gland tumors. SMP30 expression significantly increased in grade 2 carcinoma compared to grade 1 carcinoma, indicating that SMP30 expression corresponds to the malignancy of neoplastic epithelial cells (** p < 0.01).